ZA935532B - Crystalline amifostine compositions and methods for the preparation and use of same - Google Patents

Crystalline amifostine compositions and methods for the preparation and use of same

Info

Publication number
ZA935532B
ZA935532B ZA935532A ZA935532A ZA935532B ZA 935532 B ZA935532 B ZA 935532B ZA 935532 A ZA935532 A ZA 935532A ZA 935532 A ZA935532 A ZA 935532A ZA 935532 B ZA935532 B ZA 935532B
Authority
ZA
South Africa
Prior art keywords
preparation
methods
same
crystalline amifostine
compositions
Prior art date
Application number
ZA935532A
Other languages
English (en)
Inventor
Paul E Kennedy
Roger A Rajewski
John M Baldoni
Original Assignee
Us Bioscience
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25447813&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA935532(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Us Bioscience filed Critical Us Bioscience
Publication of ZA935532B publication Critical patent/ZA935532B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/16—Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165—Esters of thiophosphoric acids
    • C07F9/1651—Esters of thiophosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA935532A 1992-07-31 1993-07-30 Crystalline amifostine compositions and methods for the preparation and use of same ZA935532B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92292992A 1992-07-31 1992-07-31

Publications (1)

Publication Number Publication Date
ZA935532B true ZA935532B (en) 1994-02-24

Family

ID=25447813

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935532A ZA935532B (en) 1992-07-31 1993-07-30 Crystalline amifostine compositions and methods for the preparation and use of same

Country Status (8)

Country Link
US (1) US5424471A (fr)
EP (2) EP1243272A3 (fr)
KR (1) KR100297613B1 (fr)
FI (1) FI117924B (fr)
HK (1) HK1049280A1 (fr)
MY (1) MY110631A (fr)
WO (1) WO1994003179A1 (fr)
ZA (1) ZA935532B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US5994409A (en) * 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6239119B1 (en) * 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
US6017922A (en) 1998-05-18 2000-01-25 U.S. Bioscience, Inc. Thermally stable trimetrexates and processes for producing the same
US6384259B1 (en) * 1998-11-16 2002-05-07 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and dosage form
US6407278B2 (en) * 1998-11-16 2002-06-18 Medimmune Oncology, Inc. Stable amorphous amifostine compositions and methods for the preparation and use of the same
DK1820516T3 (da) 1999-02-22 2013-10-28 Univ Connecticut Nye albuminfrie faktor VIII-præparater
US7022315B2 (en) 2000-04-26 2006-04-04 Oregon Health & Science University Administration of a thiol-based chemoprotectant compound
DE10043170C2 (de) * 2000-09-01 2002-10-24 Klinge Co Chem Pharm Fab Amifostin-Monohydrat und Verfahren zu seiner Herstellung
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
US7629333B2 (en) * 2002-03-29 2009-12-08 Medimmune, Llc Stable amorphous amifostine compositions and methods for the preparation and use of same
SE522981C2 (sv) * 2002-07-01 2004-03-23 Nobel Biocare Ab Anordning och metod för att bibehålla nybensbildande effekt hos tillväxtstimulerande substanser vid implantatprodukt
US7604967B2 (en) * 2003-03-19 2009-10-20 The Trustees Of Dartmouth College Lignin-blocking treatment of biomass and uses thereof
WO2005048993A2 (fr) * 2003-11-14 2005-06-02 Alza Corporation Minimisation de l'oxydation des medicaments dans des formulations pharmaceutiques renfermant des excipients irradies
US20050187608A1 (en) * 2004-02-24 2005-08-25 O'hara Michael D. Radioprotective compound coating for medical devices
BRPI0509117A (pt) * 2004-03-04 2007-08-28 Wyeth Corp método de liofilização para melhorar a cristalização de excipientes
US7956160B2 (en) * 2005-07-22 2011-06-07 Amgen Inc. Concentrated protein lyophilates, methods, and uses
TW200716504A (en) * 2005-10-18 2007-05-01 jin-zhi Ye The orthopaedic implant products with controllable dissolving rate for biomedical use and the manufacturing method thereof
WO2007047315A1 (fr) * 2005-10-20 2007-04-26 Albemarle Corporation Composition cristalline de dihydrate d'amifostine
US8158152B2 (en) * 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
WO2007096901A1 (fr) * 2006-02-24 2007-08-30 Natco Pharma Limited Nouvelle forme dihydrate d'amifostine et son procédé de préparation
US20090239817A1 (en) * 2006-04-17 2009-09-24 Goverment Of The United States Of America, As Represented By The Secretary, Dept Of Health Organic thiophosphate antiretroviral agents
US9585849B2 (en) * 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
WO2008060441A2 (fr) * 2006-11-09 2008-05-22 Scidose Llc Concentré liquide d'amifostine stable
MX339060B (es) 2008-11-07 2016-05-09 Baxter Int Formulaciones del factor viii.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892824A (en) * 1968-12-16 1975-07-01 Southern Res Inst S-{107 -({107 -aminoalkylamino)alkyl dihydrogen phosphorothioates
JPS544672A (en) * 1977-06-10 1979-01-13 Taiyo Shokai Co Ltd Method and device for making material band for gusset pouch
JPS6041676B2 (ja) 1977-09-21 1985-09-18 山之内製薬株式会社 Ｓ−２−（３−アミノプロピルアミノ）エチルジハイドロジエンホスホロチオエ−ト１水和結晶の新規製法
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
DD289448A7 (de) 1982-07-29 1991-05-02 Amt Fuer Atomsicherheit Und Strahlenschutz,De Verfahren zur herstellung von s-[2-(3-amino-propylamino)ethyl]-dihydrogenthiophosphat
DD289449A7 (de) 1983-07-29 1991-05-02 Amt Fuer Atomsicherheit Und Strahlenschutz,De Verfahren zur herstellung von s-[2-(3-amino-propylamino)ethyl]-dihydrogenthiophosphat
CA1265052A (fr) * 1984-08-08 1990-01-30 Stanley J. Sarnoff Agents promoteurs d'absorption
EP0473673A4 (en) 1989-05-24 1995-05-17 Us Bioscience Method for protection from azt side effects and toxicity

Also Published As

Publication number Publication date
FI950420L (fi) 1995-03-31
KR950702424A (ko) 1995-07-29
EP1243272A3 (fr) 2003-01-22
FI117924B (fi) 2007-04-30
EP1764103A3 (fr) 2011-08-24
WO1994003179A1 (fr) 1994-02-17
KR100297613B1 (ko) 2001-10-24
EP1243272A2 (fr) 2002-09-25
EP1764103A2 (fr) 2007-03-21
US5424471A (en) 1995-06-13
MY110631A (en) 1998-09-30
HK1049280A1 (en) 2003-05-09
FI950420A0 (fi) 1995-01-31

Similar Documents

Publication Publication Date Title
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
IL104107A0 (en) New compounds and compositions
EP0707480A4 (fr) Compositions antineoplasiques et leurs procedes d'utilisation
IL108142A0 (en) Aminoureaformaldehyde fertilizer composition and its preparation
IL105939A0 (en) Herbicidal compounds and compositions
ZA931935B (en) Preparation of substituted guanidines
GB9215551D0 (en) New compositions of matter
AU2065992A (en) Herbicidal compositions and methods of preparing and using the same
HRP931429B1 (en) Process for the preparation of amlodipin benzensulphonate
EP0585168A3 (en) Composition and methods for the generation of bone
GB2264941B (en) Preparation of granular compositions
GB9108043D0 (en) Method for the formation of liposomes and compositions for use therein
GB9220143D0 (en) Compounds and compositions
AU5847694A (en) Chlorofluoroether compositions and preparation thereof
GB9225923D0 (en) New compositions of matter
GB9222985D0 (en) Use of the tarchonanthus camphoratus
ZA939155B (en) Substituted N-hydroxycinnamamides processes for their preparation compositions containing them and their use
GB9200519D0 (en) Composition of matter
GB9200689D0 (en) New compositions of matter
GB9220088D0 (en) Compounds and compositions
ZA921040B (en) Process for the preparation of 4-alkylsulfonyl-1-alkyl-2-chlorobenzenes and similar compounds
HU9601041D0 (en) Method for the preparation of quinolone-containing oral compositions
EP0564212A3 (en) Process for the preparation of arylethylamines and substituted arylethylamines
EP0564213A3 (en) Process for the preparation of arylethylamines and substituted arylethylamines
HU900600D0 (en) Herbicide compositions containing substituted sulfonyl-carbamide-derivatives and process for preparation of the agents